Skip to main content

SHELTON CAPITAL MANAGEMENT

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1002784 Denver, CO

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,145,144
-$6,366,011 QoQ
Shares Held
11,459
-34.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#341
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SHELTON CAPITAL MANAGEMENT holds $30,019,192 across 14 Biotechnology names. REGN ranks #2 (23.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
11,459 $7,145,144

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,145,144 11,459
2026-03-31 $13,511,155 17,487
2025-12-31 $13,775,563 17,847
2025-09-30 $8,426,740 14,987
2025-06-30 $9,577,050 18,242
2025-03-31 $11,719,301 18,478
2024-12-31 $13,552,078 19,025
2024-09-30 $20,189,064 19,205
2024-06-30 $22,311,264 21,228
2024-03-31 $20,214,214 21,002
2023-12-31 $13,690,784 15,588
2023-09-30 $10,072,207 12,239
2023-06-30 $6,839,782 9,519
2023-03-31 $7,492,808 9,119
2022-12-31 $6,093,704 8,446
2022-09-30 $7,006,496 10,171
2022-06-30 $5,883,516 9,953
2022-03-31 $6,951,374 9,953
2021-12-31 $7,420,991 11,751
2021-09-30 $6,854,873 11,327
2021-06-30 $7,209,075 12,907
2021-03-31 $6,106,817 12,907
2020-12-31 $4,041,215 8,365
2020-09-30 $6,922,239 12,366
2020-06-30 $5,262,358 8,438
2020-03-31 $4,120,191 8,438